Nvidia Results Quell Fears, Europe Bourses Up Midday
European bourses tracked modestly higher midday Thursday as traders leaned into tech issues after US
BTC
ETH
USDT
XRP
USDC
SOL
TRX
FIGR_HELOC
DOGE
WBT
USDS
HYPE
LEO
ADA
BTC
ETH
USDT
XRP
USDC
SOL
TRX
FIGR_HELOC
DOGE
WBT
USDS
HYPE
LEO
ADA
BTC
ETH
USDT
XRP
USDC
SOL
TRX
FIGR_HELOC
DOGE
WBT
USDS
HYPE
LEO
ADA
BTC
ETH
USDT
XRP
USDC
SOL
TRX
FIGR_HELOC
DOGE
WBT
USDS
HYPE
LEO
ADA
JPMorgan beat earnings expectations amid record market revenue, but a downbeat outlook for net interest income hurt the stock.
Most popular articles this week
Latest news from global stock markets, tech giants, and financial sectors
Browse ArticlesBitcoin, Ethereum, altcoins, DeFi, NFTs, and blockchain technology
Browse ArticlesGold, silver, oil, natural gas, and other precious commodities
Browse Articles
European bourses tracked modestly higher midday Thursday as traders leaned into tech issues after US
Futures wavered while Nvidia is holding a buy zone after strong earnings and guidance. The S&P 500 is back above its 50-day line.
Chief executive Tufan Erginbilgic raised guidance for the size of the share buyback program, free cash flow and underlying profits
Strategy's preferred equity trades back at $100 as corporate adoption expands at Strategy World 2026.
Software and chips led a rebound from Monday's sell-off ahead of Trump's State of the Union speech and Nvidia earnings.
Meta Platforms (META) landed a multi-year, 6-gigawatt GPU deal with chipmaker Advanced Micro Devices (AMD). Yahoo Finance Technology Editor Dan Howley join...
Warner Bros. Discovery shares edge lower on Paramount Skydance bid
Shares of Microsoft are less than 3% above their 200-week moving average, which has provided key technical support in the past.
21shares Spot SUI ETF (Nasdaq: TSUI) to Begin Trading on Tuesday Feb 24th, Expanding U.S. Access to Sui
European shares slip as trade uncertainty, AI-disruption fears weigh
With Nvidia earnings on tap as the stock meanders, use Stock Checkup or explore the revamped MarketSurge to apply rules for how to invest.
Novo Nordisk shares were under pressure on Monday as the struggling Danish pharmaceutical said a head-to-head study found a drug in development didn't cut...